Alimera Sciences
American biopharmaceutical sales company
Alimera Sciences, Inc. was a biopharmaceutical sales company based in Alpharetta, Georgia that specialized in the commercialization and sales of prescription ophthalmic pharmaceuticals. The company's main selling focus was on diseases affecting the back of the eye, or retina.
In September, 2024, ANI Pharmaceuticals, Inc. announced that it had completed its purchase of the company.
History
Alimera was founded in June 2003 by Dan Myers, Daniel White, Dave Holland and Mark Testerman. Three of the founders were previously part of Ciba Vision Ophthalmics, which was renamed Novartis Ophthalmics following a merger.
In 2004, Alimera Sciences introduced Soothe emollient (lubricant) eye drops for people with dry eyes. Soothe was the first lubricant eye drop to feature Restoryl, a lipid restorative that works to re-establish the lipid (oily) layer of tears, promoting sustained moisture retention. Soothe was a mineral oil in water emulsion developed by Chris Brancewicz (then at Clarkson University) for Ocular Research of Boston from 1996 to 2001.
This brief starts where responsible research should: with the source description of “Alimera Sciences” as american biopharmaceutical sales company. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the history & society register because the source frames it as american biopharmaceutical sales company. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Contemporary correspondence, administrative files and participant testimony can test how later narratives organized the event or institution. The source revision retrieved here is dated Jun 14, 2026. The linked authority identifier is Q4726659. 2 of 2 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 2024, 2003, 2004 and 1996.
Later summaries often reconcile disputed chronology or motive more neatly than the contemporary record permits. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “Alimera Sciences”, its source revision and the description used here.
- Expand the search: follow Alimera Sciences primary sources, Alimera Sciences archive and Alimera research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Alimera Sciences”?
- Which voices are present, absent or mediated by the institution?
- Who created the surviving record, and for what administrative purpose?
Search terms from this dossier
This entry incorporates text from “Alimera Sciences” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.